ATE359078T1 - Trizyklische 1-((3-indol-3-yl)-carbonyl)- piperazin-derivate als cannabinoid-cb1- rezeptoragonisten - Google Patents

Trizyklische 1-((3-indol-3-yl)-carbonyl)- piperazin-derivate als cannabinoid-cb1- rezeptoragonisten

Info

Publication number
ATE359078T1
ATE359078T1 AT04804784T AT04804784T ATE359078T1 AT E359078 T1 ATE359078 T1 AT E359078T1 AT 04804784 T AT04804784 T AT 04804784T AT 04804784 T AT04804784 T AT 04804784T AT E359078 T1 ATE359078 T1 AT E359078T1
Authority
AT
Austria
Prior art keywords
alkyl
pain
indol
alkyloxy
carbonyl
Prior art date
Application number
AT04804784T
Other languages
English (en)
Inventor
Julia Adam-Worrall
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Application granted granted Critical
Publication of ATE359078T1 publication Critical patent/ATE359078T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04804784T 2003-12-17 2004-12-13 Trizyklische 1-((3-indol-3-yl)-carbonyl)- piperazin-derivate als cannabinoid-cb1- rezeptoragonisten ATE359078T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53052803P 2003-12-17 2003-12-17
EP03104768 2003-12-17

Publications (1)

Publication Number Publication Date
ATE359078T1 true ATE359078T1 (de) 2007-05-15

Family

ID=34702353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04804784T ATE359078T1 (de) 2003-12-17 2004-12-13 Trizyklische 1-((3-indol-3-yl)-carbonyl)- piperazin-derivate als cannabinoid-cb1- rezeptoragonisten

Country Status (11)

Country Link
US (1) US7772227B2 (de)
EP (1) EP1696930B1 (de)
AT (1) ATE359078T1 (de)
AU (1) AU2004298782B2 (de)
BR (1) BRPI0417626A (de)
CA (1) CA2549147C (de)
DE (1) DE602004005893T2 (de)
ES (1) ES2284076T3 (de)
IL (1) IL175675A0 (de)
MX (1) MXPA06006928A (de)
WO (1) WO2005058327A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI330635B (en) 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
CN100448849C (zh) * 2006-02-02 2009-01-07 深圳市天和医药科技开发有限公司 一种4位-酰基取代-2-甲基哌嗪化合物的制备方法
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
US9353933B2 (en) * 2009-09-25 2016-05-31 Cree, Inc. Lighting device with position-retaining element
US9216998B2 (en) * 2012-02-15 2015-12-22 Janssen Pharmaceutica Nv Tricyclic indole derivatives useful endothelial lipase inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939138A (en) 1988-12-29 1990-07-03 Sterling Drug Inc. 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines
NZ233285A (en) 1989-04-18 1992-06-25 Duphar Int Res Imidazole-substituted carbamoyl-indoles and condensed analogues thereof and pharmaceutical compositions
EP0922042A1 (de) 1996-08-09 1999-06-16 Smithkline Beecham Corporation Neue piperazin-verbindungen
CA2340445A1 (en) 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
WO2001043746A1 (fr) 1999-12-14 2001-06-21 Nippon Shinyaku Co., Ltd. Composition medicinale
EP1254115A2 (de) * 2000-02-11 2002-11-06 Bristol-Myers Squibb Company Cannabinoid-rezeptor modulatoren, verfahren zu ihrer herstellung, und verwendung der cannabinoid-rezeptor modulatoren um respiratorische und nicht respiratorische krankheiten zu behandeln
TW200402417A (en) * 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
AU2004298782B2 (en) 2010-06-17
AU2004298782A1 (en) 2005-06-30
DE602004005893T2 (de) 2007-09-06
IL175675A0 (en) 2006-09-05
US7772227B2 (en) 2010-08-10
CA2549147A1 (en) 2005-06-30
EP1696930B1 (de) 2007-04-11
ES2284076T3 (es) 2007-11-01
US20070088025A1 (en) 2007-04-19
EP1696930A1 (de) 2006-09-06
WO2005058327A1 (en) 2005-06-30
MXPA06006928A (es) 2006-09-04
CA2549147C (en) 2012-04-10
BRPI0417626A (pt) 2007-03-27
DE602004005893D1 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
CY1107677T1 (el) Παραγωγα της 1-[indol-3-yl)carbonyl]piperazine
ATE376547T1 (de) Derivate des indol-typs als p38 kinase inhibitoren
ATE292118T1 (de) Pyrazolderivative als p-38 map kinase inhibitoren
CY1116183T1 (el) Πιπεραζινοδιονες ως ανταγωνιστες υποδοχεα οξυτοκινης
IL175675A0 (en) Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid cb1 receptor agonists
DE602007007065D1 (de) Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53
TW200626579A (en) Inhibitors of the interaction between MDM2 and p53
CA2426031A1 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
TW200800938A (en) Indole carboxylic acid derivatives exhibiting PGD2 receptor antagonism
EA200600364A1 (ru) Производные (тио)карбамоилциклогексана в качестве антагонистов d/dрецептора
DE60208568D1 (de) Prostaglandinanaloga als ep4-rezeptoragonisten
AR035401A1 (es) El uso de compuestos derivados de feniletenilo y feniletinilo; compuestos derivados de feniletinilo; compuestos derivados de feniletenilo; un procedimiento para la elaboracion de los mismos; y medicamentos que los contienen
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
MXPA05010816A (es) Derivados de 4-(4- (heterociclilalcox}fenil)- 1-(heterociclil- carbonil) piperidina y compuestos relacionados como antagonistas de h3 de la histamina para el tratamiento de enfermedades neurologicas tales como alzheimer.
CY1107953T1 (el) Ενωσεις υποκαθιστουμενης βενζιμιδαζολης και η χρηση τους για τη θεραπεια του καρκινου
TW200613297A (en) Pyrazole derivatives
ATE291018T1 (de) Pyrazol verbindungen und ihre verwendung
HUP0203722A2 (hu) Helyettesített fenilpiperazin-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
RS20060502A (en) (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
HUP0402500A2 (hu) Gyulladáskeltő citokinok kibocsátását gátló heterokondenzált pirazol-3-on vegyületek és az ezeket tartalmazó gyógyszerkészítmények
DE60004340D1 (de) Substituierte 1,4-dihydroindeno[1,2-c]pyrazole als inhibitoren von tyrosinkinase
MXPA05010651A (es) Compuestos de pirazol.
ATE364384T1 (de) Benzylimidazolyl substituierte 2-chinolon und chinazolinon derivate zur verwendung als farnesyl transferase inhibitoren
ATE355265T1 (de) Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren
MXPA05010650A (es) Pirazoles sustituidos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties